← Back to Search

Prehabilitation for Frailty

N/A
Recruiting
Led By Dae Hyun M Kim, MD, ScD
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient is scheduled to have a gastrointestinal, gynecological oncologic, and urologic surgery
Patient's frailty index is ≥0.25
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial aims to see if it's possible to provide a pre-surgery program for older adults and measure how it affects their well-being before a major surgery.

Who is the study for?
This trial is for older adults who are frail (with a frailty index of 0.25 or higher) and scheduled for major gastrointestinal, gynecological oncologic, or urologic surgery. Participants must be able to give informed electronic or remote consent.Check my eligibility
What is being tested?
The study tests whether a combination of cognitive behavioral therapy, exercise routines, meditation practices, and nutritional planning can improve outcomes for patients before they undergo major elective surgeries.See study design
What are the potential side effects?
Since the interventions include non-invasive techniques like counseling, physical activity, relaxation exercises, and diet changes rather than medications or surgeries, significant side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for surgery related to my digestive, reproductive, or urinary system cancer.
Select...
My frailty index is 0.25 or higher.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of the prehabilitation program
Secondary outcome measures
Adherence to exercise
Adherence to meditation
Adherence to protein intake
+13 more
Other outcome measures
3-D Confusion Assessment Method
30-day mortality from all causes
30-day readmission from all causes
+4 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: PrehabilitationExperimental Treatment4 Interventions
This group will receive a multicomponent prehabilitation intervention (exercise, nutritional intervention, meditation, and cognitive behavioral intervention) for 3-4 weeks prior to surgery.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Meditation
2021
Completed Phase 3
~2740
Exercise
2016
Completed Phase 1
~760
Cognitive Behavioral Intervention
2010
Completed Phase 2
~1040
Nutrition
2011
Completed Phase 3
~58070

Find a Location

Who is running the clinical trial?

Beth Israel Deaconess Medical CenterLead Sponsor
838 Previous Clinical Trials
13,010,462 Total Patients Enrolled
1 Trials studying Frailty
800 Patients Enrolled for Frailty
Hebrew SeniorLifeOTHER
46 Previous Clinical Trials
270,739 Total Patients Enrolled
2 Trials studying Frailty
166 Patients Enrolled for Frailty
Dae Hyun M Kim, MD, ScDPrincipal InvestigatorBeth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being enrolled in this clinical trial?

"Indeed, the details on clinicaltrials.gov reveal that recruitment is ongoing for this investigation. The trial was first listed on March 27th, 2023 and underwent its most recent update on February 4th, 2024. They aim to enlist a total of 30 individuals at one designated site."

Answered by AI

What is the current participation count in this clinical trial?

"Indeed, data from clinicaltrials.gov indicates that this study is actively seeking participants. It was initially posted on March 27th, 2023 and last modified on February 4th, 2024. The trial aims to recruit a total of 30 individuals at one designated site."

Answered by AI
~14 spots leftby May 2025